Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Sunday, November 20, 2011

Chronic alcoholism increases the induction dose of propofol

The present study was designed to investigate the possible effect of chronic alcohol intake on propofol and remifentanil requirements, which was determined by quantifying the 50% (EC50) and 95% (EC95) effective effect-site concentrations for propofol and remifentanil at loss of consciousness (LOC) and after a painful stimulus.

Thirty male patients (alcoholic group; n = 30) with chronic alcoholism and 30 patients (control group; n = 30) with a history of small alcohol intake were anaesthetized with propofol and remifentanil by target-controlled infusion. The predicted drug concentrations and Bispectral Index (BIS) values were recorded at LOC and after no response to painful stimuli.

The EC50 and EC95 of propofol at LOC in alcoholic group were 3.15 [95% confidence interval (CI), 2.77–3.37] and 4.05 (95% CI, 3.18–5.26) μg/ml, respectively, and those of the control group were 2.21 (95% CI, 1.92–2.86) and 3.04 (95% CI, 2.45–4.64) μg/ml, respectively. The EC50 and EC95 of remifentanil measured after no response to painful stimuli in the alcoholic group were 3.02 (95% CI, 2.70–3.38) and 4.98 (95% CI, 4.56–5.89) ng/ml, respectively, and those of the control group were 2.95 (95% CI, 2.68–3.33) and 4.86 (95% CI, 4.55–5.92) ng/ml, respectively. The EC50 and EC95 values of propofol at LOC in the control group were significantly lower than that of the alcoholic group.

These findings suggest that the induction dose requirements of propofol are increased in alcoholic patients anaesthetized with propofol and remifentanil administered by target controlled infusion.


Read Full Abstract

Request Reprint E-Mail: zhanggangxue123@yahoo.cn